The Swedish Pavilion at BIO International 2026 – Co-organizers and Partners

Published on July 3, 2026
See the full list here
Continue reading on website
Other news

From CDMO to AI, Korean biotechs make their case at BIO USA 2026

June 23, 2026
SAN DIEGO, Calif. — By Lee Han-soo / Korea Biomedical Review correspondent — Korean pharmaceutical, biotech, hospital and academic players are making a broader global partnering push at the 2026 BIO International Convention, or BIO USA 2026, which kicked off its four-day run in San Diego, California, on Monday.Held at the San Diego Convention Center under the theme “Driven by Purpose,” this year’s

FORUS Therapeutics Inc – Announces Health Canada Approval of BESREMI® (ropeginterferon alfa-2b) for Polycythemia Vera (PV)

July 6, 2026
(OAKVILLE, Ontario) July 6, 2026 ­– FORUS Therapeutics Inc (“FORUS”), a wholly owned subsidiary of PharmaEssentia Corp, is pleased to announce that it has received a Notice of Compliance (NOC) authorizing BESREMI® (ropeginterferon alfa-2b) for the treatment of adults with polycythemia vera (PV). BESREMI® is expected to become commercially available in Canada in the coming weeks.Polycythemia vera i